Skip to main content
SPT Energy Group Inc. logo

SPT Energy Group Inc. — Investor Relations & Filings

Ticker · 1251 ISIN · KYG8405W1069 HKEX Mining and quarrying
Open in API
Filings indexed 1,533 across all filing types
Latest filing 2019-01-16 Regulatory Filings
Country HK Hong Kong
Listing HKEX 1251

About SPT Energy Group Inc.

http://www.sptenergygroup.com

SPT Energy Group Inc. is an international integrated oilfield services company specializing in oilfield exploration and development, oilfield services, and the new energy sector. The company provides comprehensive technical solutions across multiple divisions. Key offerings include Drilling Services, encompassing drilling rig operations, complex well workover, fishing, cementing, and drilling fluid services. The Reservoir Services Division delivers geological studies, dynamic monitoring, and reservoir management solutions. Furthermore, the group manufactures and sells specialized oilfield service products. SPT Energy Group serves the petroleum, petrochemical, and pipeline sectors, with primary operations in the People's Republic of China, Kazakhstan, and Turkmenistan.

Recent filings

Filing Released Lang Actions
VOLUNTARY ANNOUNCEMENT - ANNOUNCEMENT IN RELATION TO COMPLETION OF EQUITY DIVERSIFICATION REFORM OF CHINA NATIONAL PHARMACEUTICAL GROUP CORPORATION, THE BENEFICIAL CONTROLLER
Regulatory Filings Classification · 95% confidence The document is a voluntary announcement by China Traditional Chinese Medicine Holdings Co. Limited regarding the completion of an equity diversification reform of its beneficial controller, China National Pharmaceutical Group Corporation (CNPGC). It discusses changes in the ownership structure of CNPGC and confirms that CNPGC remains the beneficial controller with no change in shareholding proportion. The document is relatively short (2743 characters) and does not contain financial statements, detailed financial data, or comprehensive report content. It is an announcement about a corporate governance event related to ownership structure and control, but not a formal management change announcement or detailed governance report. It does not fit into categories like Annual Report, Interim Report, or Earnings Release. It is not a regulatory filing or certification letter either. Given the nature of the content, it best fits under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2019-01-16 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2018
Share Issue/Capital Change Classification · 95% confidence The document is titled 'Monthly Return of Equity Issuer on Movements in Securities' for the month ended 31/12/2018, submitted to the Hong Kong Exchanges and Clearing Limited. It details movements in authorised share capital, issued share capital, share options, warrants, convertibles, and other share-related activities. There is no financial performance data, earnings information, or management discussion. The content focuses exclusively on share capital changes and securities movements, which aligns with announcements related to share capital changes rather than full financial reports or earnings releases. Therefore, the document fits best under the category 'Share Issue/Capital Change' (SHA). The document length is substantial and contains detailed data, confirming it is the report itself, not just an announcement of a report.
2019-01-04 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 DECEMBER 2018
Capital/Financing Update Classification · 95% confidence The document is titled 'Monthly Return of Equity Issuer on Movements in Securities' for the month ended 31/12/2018, submitted to the Hong Kong Exchanges and Clearing Limited. It details movements in authorized and issued share capital, share options, warrants, convertibles, and other share-related capital changes for the issuer China Traditional Chinese Medicine Holdings Co. Limited. The content is focused on share capital changes and movements during a specific month, which aligns with a capital or financing update rather than a full financial report or other categories. The document is substantive and detailed, not merely an announcement or certification. Therefore, it fits best under the category of Capital/Financing Update (CAP).
2019-01-03 English
CHANGE OF DIRECTORS, COMPOSITION OF THE BOARD COMMITTEES, CHIEF FINANCIAL OFFICER AND VICE PRESIDENTS
Board/Management Information Classification · 95% confidence The document is an announcement from China Traditional Chinese Medicine Holdings Co. Limited regarding multiple changes in the company's board of directors, board committees, chief financial officer, and vice presidents. It details resignations and appointments of directors and senior management, including biographical information and terms of appointment. There is no financial data, earnings information, or report publication mentioned. The content focuses exclusively on management and board composition changes. Therefore, this document fits the category of Board/Management Information (MANG). The document length is substantial and contains detailed information about management changes, not just a brief notice or regulatory filing. Hence, the classification is MANG with high confidence.
2018-12-24 English
List of Directors and their Role and Function
Board/Management Information Classification · 100% confidence The document lists the members of the board of directors and their roles and functions, including committee memberships. It is a formal announcement about the composition and structure of the company's board. There is no financial data, no discussion of financial results, no voting results, no legal proceedings, no capital changes, and no mention of any report publication. The content fits the category of Board/Management Information, which covers announcements of changes or details about the company's board of directors or senior management.
2018-12-24 English
VOLUNTARY ANNOUNCEMENT - SINOPHARM GROUP ZHONGLIAN PHARMACEUTICAL CO., LTD. BECOME ONE OF THE PILOT MANUFACTURERS OF CONCENTRATED TCM GRANULES IN HUBEI PROVINCE
Regulatory Filings Classification · 95% confidence The document is a voluntary announcement by China Traditional Chinese Medicine Holdings Co. Limited regarding a business development: Sinopharm Group Zhonglian Pharmaceutical Co., Ltd., a subsidiary, becoming a pilot manufacturer of concentrated TCM granules in Hubei Province. It contains no financial statements, no regulatory certifications, no voting results, no management changes, no earnings data, and no detailed report content. The document is relatively short (3578 characters) and serves to inform shareholders and investors about a business update. It is not a report itself but an announcement of a business development. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2018-12-17 English

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.